Novartis acquires Endocyte for 2.1 Billion Cash deal

Like
Like Love Haha Wow Sad Angry

Novartis acquires Endocyte Shares of Indiana-based Endocyte have taken up more than 50 percent in pre-market trading following Swiss pharma giant Novartis declared that it was acquiring the company for $2.1 billion in cash. The deal will enable the company to expand its radiopharmaceuticals business. The announcement of Novartis acquires Endocytedeal came months after Endocyte […]

The post Novartis acquires Endocyte for 2.1 Billion Cash deal appeared first on BioTecNika .Read more at www.biotecnika.org/2018/10/novartis-acquires-endocyte/

Like
Like Love Haha Wow Sad Angry